awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36541100-DE7F3FAD-104C-4187-954A-643FBDB44EF0
Q36541100-DE7F3FAD-104C-4187-954A-643FBDB44EF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36541100-DE7F3FAD-104C-4187-954A-643FBDB44EF0
Experience with imidafenacin in the management of overactive bladder disorder
P2860
Q36541100-DE7F3FAD-104C-4187-954A-643FBDB44EF0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36541100-DE7F3FAD-104C-4187-954A-643FBDB44EF0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ad4aae8782d92b98108d36c79221c5ac43dedeac
P2860
A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder.